Fledelius, J., Winther-Larsen, A., Khalil, A. A., Hjorthaug, K., Frøkiær, J., & Meldgaard, P. (2018). Assessment of very early response evaluation with (18)F-FDG-PET/CT predicts survival in erlotinib treated NSCLC patients-A comparison of methods. Am J Nucl Med Mol Imaging.
Citación estilo ChicagoFledelius, Joan, Anne Winther-Larsen, Azza A. Khalil, Karin Hjorthaug, Jørgen Frøkiær, y Peter Meldgaard. "Assessment of Very Early Response Evaluation With (18)F-FDG-PET/CT Predicts Survival in Erlotinib Treated NSCLC Patients-A Comparison of Methods." Am J Nucl Med Mol Imaging 2018.
Cita MLAFledelius, Joan, et al. "Assessment of Very Early Response Evaluation With (18)F-FDG-PET/CT Predicts Survival in Erlotinib Treated NSCLC Patients-A Comparison of Methods." Am J Nucl Med Mol Imaging 2018.